Evidence map›Paper›PMID 32123084›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Mechanism of proton transfer in class A β-lactamase catalysis and inhibition by avibactam.

Orville A Pemberton, Radwan E Noor, Vasantha Kumar M V, Ruslan Sanishvili, M Trent Kemp, Fiona L Kearns, H Lee Woodcock, Ioannis Gelis, Yu Chen

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. NMR crystallography reveals active-site protonation states of Toho-1 β-lactamase in complex with avibactam.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Directed evolution of a beta-lactamase samples a wide variety of conformational states.Protein science : a publication of the Protein Society · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Exploring avibactam and relebactam inhibition ofAntimicrobial agents and chemotherapy · 2023
    Article
  12. The Influence of Outer Membrane Protein on Ampicillin Resistance ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Article
  13. Article
  14. Article
  15. The biogenesis of β-lactamase enzymes.Microbiology (Reading, England) · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Orville A PembertonDepartment of Molecular Medicine, University of South Florida, Tampa, FL 33612.
Radwan E NoorDepartment of Chemistry, University of South Florida, Tampa, FL 33620.
Vasantha Kumar M VDepartment of Chemistry, University of South Florida, Tampa, FL 33620.
Ruslan SanishviliGM/CA@APS, X-ray Science Division, Advanced Photon Source, Argonne National Laboratory, Argonne, IL 60439.
M Trent KempDepartment of Molecular Medicine, University of South Florida, Tampa, FL 33612.
Fiona L KearnsDepartment of Chemistry, University of South Florida, Tampa, FL 33620.
H Lee WoodcockDepartment of Chemistry, University of South Florida, Tampa, FL 33620.
Ioannis GelisDepartment of Chemistry, University of South Florida, Tampa, FL 33620; igelis@usf.edu ychen1@health.usf.edu.
Yu ChenDepartment of Molecular Medicine, University of South Florida, Tampa, FL 33612; igelis@usf.edu ychen1@health.usf.edu.
University of South Florida · USArgonne National Laboratory · US

Funding

Evolution and inhibition of beta-lactamase activity in antibiotic resistanceR01AI103158 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI CHEN, YU · 2013 to 2017
$2.0M
Design and application ofrobust and efficient QM/MM free energy simulation methods for biomolecular systemsR01GM129519 · NIGMS · UNIVERSITY OF SOUTH FLORIDA · PI WOODCOCK III, HENRY LEE · 2018 to 2025
$1.9M
Assembly mechanism of cochaperone-kinase complexesR01GM115854 · NIGMS · UNIVERSITY OF SOUTH FLORIDA · PI GELIS, IOANNIS · 2015 to 2019
$1.6M
Novel inhibitor discovery against Pseudomonas aeruginosa PBP3R21AI147654 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI CHEN, YU · 2019 to 2020
$411k
NIAID NIH HHS R01 AI103158NIAID NIH HHS R21 AI147654NIGMS NIH HHS R01 GM115854NIGMS NIH HHS R01 GM129519
6 · The paper itself

Abstract

Gram-negative bacteria expressing class A β-lactamases pose a serious health threat due to their ability to inactivate all β-lactam antibiotics. The acyl-enzyme intermediate is a central milestone in the hydrolysis reaction catalyzed by these enzymes. However, the protonation states of the catalytic residues in this complex have never been fully analyzed experimentally due to inherent difficulties. To help unravel the ambiguity surrounding class A β-lactamase catalysis, we have used ultrahigh-resolution X-ray crystallography and the recently approved β-lactamase inhibitor avibactam to trap the acyl-enzyme complex of class A β-lactamase CTX-M-14 at varying pHs. A 0.83-Å-resolution CTX-M-14 complex structure at pH 7.9 revealed a neutral state for both Lys73 and Glu166. Furthermore, the avibactam hydroxylamine-

Indexed as

ProtonsAcylationAzabicyclo CompoundsBacterial Proteinsbeta-Lactamase Inhibitorsbeta-LactamasesBinding SitesCatalysisCrystallography, X-RayEscherichia coliHydrogen-Ion ConcentrationModels, MolecularMolecular ConformationProtein ConformationavibactamAzabicyclo CompoundsBacterial Proteinsbeta-lactamase CTX-M-14beta-Lactamase Inhibitorsbeta-LactamasesProtonsacyl–enzymeavibactambeta-lactamase inhibitorpKa perturbationserine beta-lactamase

Identifiers

PMID32123084
PMCPMC7084157
OpenAlexW3009722467

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.